Refining Rare Disease Targeting with Real-World Data
A mid-sized pharmaceutical company leveraged NorstellaLinQ to refine rare disease patient targeting with integrated real-world data. By combining EHR physician notes, claims data, and patient journey analysis, the company identified overlooked patient populations, mapped the physicians diagnosing and treating them, and generated actionable insights to improve commercial targeting and early product planning. The company: Learned […]
Delivering the Depth and Detail Neurology Deserves
Neurology therapies face some of the greatest hurdles to early diagnosis, access, and adoption. This infographic highlights how NorstellaLinQ captures what others miss—unlocking the full complexity of the patient journey so you can drive faster diagnosis, generate stronger evidence, position therapies more effectively, and deliver better outcomes for patients who need them most. Download the […]
Introducing Trigger Alerts
Claims data can’t tell you what’s actually happening with your patients—not why treatment changed, what the latest labs revealed, or whether a physician is considering switching therapies. This infographic explores how Trigger Alerts powered by NorstellaLinQ bring you closer to the patient, earlier in their journey, with the clarity your brand and sales teams need […]
Get Closer to the Patient Than Ever Before with NorstellaLinQ EHR Data
If you’re only using claims and national reference lab data, you’re overlooking critical insights—like specialty pharmacy fills, treatment modifications, and physician rationale—that reveal the real drivers behind prescribing behavior. This infographic explores how NorstellaLinQ EHR fills these gaps with structured and unstructured clinical data that helps you see more, understand faster, and act smarter. What’s […]
Targeting Patients and Fueling Brand Strategy with Trigger Alerts
Discover how AI-powered Trigger Alerts and integrated real-world data helped identify high-risk patients, equip field teams with timely clinical insights, and strengthen brand engagement strategies. Identified high-risk patients with AI-powered Trigger Alerts Delivered timely clinical insights to field teams Strengthened brand strategy with integrated real-world data
Global Pharmaceutical Company Leverages IHD Analytics Platform to Train and Educate Employees on Real-World Data Analytics and AI/ML Methodology
See how an internal datathon helped a global pharmaceutical company strengthen real-world data capabilities, foster cross-functional collaboration, and accelerate healthcare analytics innovation to: Build real-world data and AI/ML expertise across teams Accelerate analytics with an intuitive self-service platform Reduce reliance on external vendors for faster insights
How Unstructured EMR Data Helps Pharma Find Patients
As therapies have become more complex, pharma companies are now challenged to achieve precision targeting within a much tighter timeframe. While claims data is readily available, one of its key limitations is the lack of timeliness. Many manufacturers now rely on specialized lab data—from imaging results to genetic testing and genomics—to identify eligible patients and […]
Uncovering New Rare Disease Patients Using Structured and Unstructured Real-World Data
Learn how integrated structured and unstructured real-world data helped identify rare disease patients, quantify the addressable population, and strengthen commercial and payer strategies ahead of launch. Identified hidden rare disease patients with integrated real-world data Quantified the addressable patient population with confidence Strengthened launch and payer strategies with actionable insights
Connecting the Dots with NorstellaLinQ
Norstella’s VP of thought leadership, Daniel Chancellor, was invited to share his perspectives on the proliferation of data with the leading publication The Medicine Maker. The timing was perfect, coming shortly after we launched NorstellaLinQ, the biopharma industry’s first fully integrated data asset. The article explores various themes such as abundance, the importance of data […]
Breaking Barriers in Rare Disease Drug Development
Bringing rare disease treatments from pipeline to patient Rare diseases affect more than 395 million people worldwide, yet only 5% have an FDA-approved treatment. The challenges of small patient populations, regulatory complexities, and limited clinical data have historically slowed progress. But the landscape is changing. This infographic explores the key barriers in rare disease drug […]
